These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2548639)

  • 1. Inhibition of platelet-von Willebrand factor binding to platelets by adhesion site peptides.
    Parker RI; Gralnick HR
    Blood; 1989 Sep; 74(4):1226-30. PubMed ID: 2548639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S; Gralnick H
    Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor.
    Dardik R; Ruggeri ZM; Savion N; Gitel S; Martinowitz U; Chu V; Varon D
    Thromb Haemost; 1993 Sep; 70(3):522-6. PubMed ID: 8259558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen.
    Fressinaud E; Girma JP; Sadler JE; Baumgartner HR; Meyer D
    Thromb Haemost; 1990 Dec; 64(4):589-93. PubMed ID: 2084945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
    Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
    J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S; Kloczewiak M; Hawiger J
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
    Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP.
    Adelman B; Carlson P; Powers P
    Blood; 1987 Nov; 70(5):1362-6. PubMed ID: 2822171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.
    Beacham DA; Wise RJ; Turci SM; Handin RI
    J Biol Chem; 1992 Feb; 267(5):3409-15. PubMed ID: 1737795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
    Chow TW; Hellums JD; Moake JL; Kroll MH
    Blood; 1992 Jul; 80(1):113-20. PubMed ID: 1611079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions.
    Nievelstein PF; Sixma JJ
    Blood; 1988 Jul; 72(1):82-8. PubMed ID: 2968824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.
    Nierodzik ML; Plotkin A; Kajumo F; Karpatkin S
    J Clin Invest; 1991 Jan; 87(1):229-36. PubMed ID: 1845869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function.
    van Wyk V; Leblond L; Winocour PD; Devine DV; Gyongyossy-Issa MI
    Thromb Res; 2000 Aug; 99(4):343-52. PubMed ID: 10963785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.
    Parker RI; Gralnick HR
    Blood; 1986 Sep; 68(3):732-6. PubMed ID: 3017478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.